The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, K.-N.
Right arrow Articles by Hirsch, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, K.-N.
Right arrow Articles by Hirsch, R.
The Journal of Immunology, 2000, 164: 1576-1581.
Copyright © 2000 by The American Association of Immunologists

Viral IL-10 and Soluble TNF Receptor Act Synergistically to Inhibit Collagen-Induced Arthritis Following Adenovirus- Mediated Gene Transfer1

Kwang-Nam Kim, Shohei Watanabe, Yuhe Ma, Sherry Thornton, Edward H. Giannini and Raphael Hirsch2

William S. Rowe Division of Rheumatology, Children’s Hospital Medical Center, Cincinnati, OH 45229

Viral IL-10 (vIL-10) and soluble TNF receptor (sTNFR) are anti-inflammatory proteins that can suppress collagen-induced arthritis (CIA). These and related proteins have shown efficacy in the treatment of human rheumatoid arthritis; however, neither alone is able to completely suppress disease. Furthermore, they have short half-lives, necessitating frequent administration. To determine the ability of these proteins to act synergistically following gene transfer, arthritis was induced in DBA/1 male mice by immunization with type II collagen on days 0 and 21. Mice were injected i.v. either before disease onset (day 20) or after disease onset (day 28) with 1010 particles of adenovirus encoding vIL-10, a soluble TNF receptor-IgG1 fusion protein (sTNFR-Ig), a combination of both vectors, or a control vector lacking a transgene. Significant synergism was observed with the combination of vIL-10 and sTNFR-Ig, with a substantial reduction in both the incidence and severity of disease as well as inhibition of progression of established disease. sTNFR-Ig alone had no effect on CIA. vIL-10 alone inhibited disease when given before disease onset, but had minimal effect on established disease. Both proteins inhibited spleen cell proliferation and IFN-{gamma} secretion in response to stimulation with type II collagen, but only vIL-10 reduced the synovial mRNA levels of the proinflammatory cytokines IL-1ß, TNF-{alpha}, and IL-6. These findings demonstrate that vIL-10 and sTNFR-Ig act synergistically in suppressing CIA and suggest that gene transfer offers a potential therapeutic modality for the treatment of arthritis.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Ferretti, R. Gassner, Z. Wang, P. Perera, J. Deschner, G. Sowa, R. B. Salter, and S. Agarwal
Biomechanical Signals Suppress Proinflammatory Responses in Cartilage: Early Events in Experimental Antigen-Induced Arthritis
J. Immunol., December 15, 2006; 177(12): 8757 - 8766.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-H. Kim, E. R. Lechman, N. Bianco, R. Menon, A. Keravala, J. Nash, Z. Mi, S. C. Watkins, A. Gambotto, and P. D. Robbins
Exosomes Derived from IL-10-Treated Dendritic Cells Can Suppress Inflammation and Collagen-Induced Arthritis
J. Immunol., May 15, 2005; 174(10): 6440 - 6448.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Lucas and G. McFadden
Secreted Immunomodulatory Viral Proteins as Novel Biotherapeutics
J. Immunol., October 15, 2004; 173(8): 4765 - 4774.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Suda, T. Tagawa, S. A. Kanaan, B. D. Kozower, N. Daddi, T. Mohanakumar, and G. A. Patterson
Adenovirus encoding soluble tumor necrosis factor {alpha} receptor immunoglobulin prolongs gene expression of a cotransfected reporter gene in rat lung
J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1155 - 1161.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Zuo, C. M. Cullen, M. L. DeLay, S. Thornton, L. K. Myers, E. F. Rosloniec, G. P. Boivin, and R. Hirsch
A Single-Chain Class II MHC-IgG3 Fusion Protein Inhibits Autoimmune Arthritis by Induction of Antigen-Specific Hyporesponsiveness
J. Immunol., March 1, 2002; 168(5): 2554 - 2559.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. C. M. Johansson, A.-S. Hansson, K. S. Nandakumar, J. Backlund, and R. Holmdahl
IL-10-Deficient B10.Q Mice Develop More Severe Collagen-Induced Arthritis, but Are Protected from Arthritis Induced with Anti-Type II Collagen Antibodies
J. Immunol., September 15, 2001; 167(6): 3505 - 3512.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Quattrocchi, M. J. Dallman, A. P. Dhillon, A. Quaglia, G. Bagnato, and M. Feldmann
Murine IL-10 Gene Transfer Inhibits Established Collagen-Induced Arthritis and Reduces Adenovirus-Mediated Inflammatory Responses in Mouse Liver
J. Immunol., May 15, 2001; 166(10): 5970 - 5978.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. H. Kim, S. Kim, C. H. Evans, S. C. Ghivizzani, T. Oligino, and P. D. Robbins
Effective Treatment of Established Murine Collagen-Induced Arthritis by Systemic Administration of Dendritic Cells Genetically Modified to Express IL-4
J. Immunol., March 1, 2001; 166(5): 3499 - 3505.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
W. C. Russell
Update on adenovirus and its vectors
J. Gen. Virol., November 1, 2000; 81(11): 2573 - 2604.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.